Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06724627 · ClinicalTrials.gov registry record · NA

Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting

A NA study of Skin Condition and Dermatology/Skin - Other, sponsored by BelleTorus Corporation.

Recruiting
Registry status
NA
Development phase
263
Enrollment target
1
Study location

NCT06724627 is a NA study of Skin Condition and Dermatology/Skin - Other that is actively recruiting participants, run by BelleTorus Corporation. The registered enrollment target is 263 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06724627, a NA study of Skin Condition and Dermatology/Skin - Other, is actively recruiting participants, sponsored by BelleTorus Corporation.

RECRUITING
Registry status
NA
Development phase
263 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions. This tool is an AI-powered dermatology image reference app that works with a smartphone. For clarity, the AI makes no diagnoses; it provides reference images. Primary care providers then use their own medical judgement and training to make the diagnosis. The sponsor aims to compare the diagnoses made by primary care providers (such as doctors, nurse practitioners, and physician assistants) with the support of the AI tool compared to a panel of dermatologists, who are setting the gold standard. By doing so, the sponsor can determine the value of the AI tool for primary care providers and understand how it might be used alongside traditional clinical care. This AI capability complies with FDA regulatory guidelines and is not considered a medical device, similar to a Google image search, which returns similar looking images for reference purposes. For intervention, they healthcare providers use their own training and clinical judgement to make the diagnosis, and not the AI.

Interventions

  • DIAGNOSTIC_TEST Dermatology/Skin - Other

Study Locations (1)

New York

  • Urban Health Plan Inc. - The Bronx

Trial Details

FieldValue
Enrollment Target 263 participants
Start Date 2024-09-16
Est. Completion 2025-06-30
Phase NA

Sponsor

BelleTorus Corporation

2 total trials

What the Registry Record Tells You About NCT06724627

The ClinicalTrials.gov registry entry for NCT06724627 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BelleTorus Corporation, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Skin Condition appearing as the primary indexed condition, and to 1 intervention - of which Dermatology/Skin - Other is the first listed.

NCT06724627 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06724627 about?

NCT06724627 is a clinical study titled "Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting". The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions. This tool is an AI-powered dermatology image reference app that works with a smartphone. For clarity, the AI makes no diagnoses; it pro...

What is the current status of trial NCT06724627?

This trial is currently recruiting. It is a NA study. The enrollment target is 263 participants. The study started on 2024-09-16. Estimated completion is 2025-06-30.

What conditions does trial NCT06724627 study?

This clinical trial studies the following conditions: Skin Condition, Dermatology/Skin - Other, Dermatology.

What interventions are being tested in trial NCT06724627?

The interventions under investigation include: Dermatology/Skin - Other (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06724627?

This trial is sponsored by BelleTorus Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06724627 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Condition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.